Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

Infectious Diseases of Humans: Dynamics and Control

(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,818 · see citing works

HUMAN IMMUNITY TO THE MENINGOCOCCUS

Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,298 · see citing works

HUMAN IMMUNITY TO THE MENINGOCOCCUS

Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 999 · see citing works

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978 · see citing works

Herd Immunity: History, Theory, Practice

Fine, P. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036121 · Cited by 906 · see citing works

ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS

Finne, J., Leinonen, M., & Mäkelä, P. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90340-9 · Cited by 798 · see citing works

Global epidemiology of meningococcal disease

Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 753 · see citing works

Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004

Hicks, L. A., Harrison, L. H., Flannery, B. L., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D. M., Thomas, A. R., Beall, B., Lynfield, R., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521626 · Cited by 736 · see citing works

A universal vaccine for serogroup B meningococcus

Giuliani, M. M., Adu‐Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 733 · see citing works

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

BJUNE, G., Høiby, E. A., Grønnesby, J. K., Arnesen, Ø. K., Fredriksen, J. H., Lindbak, A.-K., Nøkleby, H., Rosenqvist, E., Lk, S., CLOSS, O., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91961-s · Cited by 693 · see citing works

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · see citing works

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

Miller, E. J., SALISBURY, D. M., & Ramsay, M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 483 · see citing works

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Lefkowitz, L. B., Cartter, M. L., Danila, R., Cieslak, P. R., Shutt, K. A., Popović, T., Schuchat, A., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315158 · Cited by 449 · see citing works

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442 · see citing works

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination

Maiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · see citing works

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 409 · see citing works

Neisseria meningitidis: an overview of the carriage state

Yazdankhah, S. P., & Caugant, D. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45529-0 · Cited by 374 · see citing works

Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines

Tappero, J. W., Lagos, R., Ballesteros, A. M., Plikaytis, B., Williams, D. B., Dykes, J. K., Gheesling, L. L., Carlone, G. M., Høiby, E. A., Holst, J., et al. (1999) · JAMA · doi:10.1001/jama.281.16.1520 · Cited by 368 · see citing works

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

de Moraes, J. C., Camargo, M. C. C., Hidalgo, N. T., Barbosa, H. A., Gattás, V. L., Vasconcelos, H. D. G., Sacchi, C. T., Gral, I. M. L., Perkins, B. A., Wenger, J. D., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)93086-3 · Cited by 363 · see citing works

Meningococcal meningitis in Africa

Greenwood, B. M. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90106-2 · Cited by 360 · see citing works

Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery

Booy, R. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.5.386 · Cited by 281 · see citing works

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

Boslego, J. W. (1995) · Vaccine · doi:10.1016/0264-410x(94)00037-n · Cited by 267 · see citing works

Estimation of Vaccine Effectiveness Using the Screening Method

Farrington, P. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.4.742 · Cited by 261 · see citing works

Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity

Brisson, M., & Edmunds, W. J. (2003) · Medical Decision Making · doi:10.1177/0272989x02239651 · Cited by 252 · see citing works

Immunologic correlates of protection induced by vaccination

Plotkin, S. A. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00013 · Cited by 242 · see citing works

A review of vaccine research and development: Meningococcal disease☆

Girard, M. P., Preziosi, M.-P., Aguado, M. T., & Kiény, M. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.034 · Cited by 210 · see citing works

Lessons from meningococcal carriage studies

Caugant, D. A., Tzanakaki, G., & Kriz, P. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00052.x · Cited by 193 · see citing works

Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.

Campagne, G., Schuchat, A., Djibo, S., Ousseini, A., Cissé, L., & Chippaux, J. (1999) · Europe PMC (PubMed Central) · Cited by 182 · see citing works

Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination

Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi160 · Cited by 176 · see citing works

Many carried meningococci lack the genes required for capsule synthesis and transport The GenBank accession number for the sequence of the cnl-1 allele is AJ308327.

Claus, H., Maiden, M. C. J., Maag, R., Frosch, M., & Vogel, U. F. (2002) · Microbiology · doi:10.1099/00221287-148-6-1813 · Cited by 175 · see citing works

Meningococcal carriage in the African meningitis belt

Trotter, C. L., & Greenwood, B. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70288-8 · Cited by 174 · see citing works

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain

Larrauri, A., Cano, R., García, M. J. S., & de Mateo, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.045 · Cited by 171 · see citing works

Immunogenicity of Two Efficacious Outer Membrane Protein‐Based Serogroup B Meningococcal Vaccines among Young Adults in Iceland

Perkins, B. A., Jónsdóttir, K., Briem, H., Griffiths, E., Plikaytis, B., Høiby, E. A., Rosenqvist, E., Holst, J. J., Nøkleby, H., Sotolongo, F., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514232 · Cited by 170 · see citing works

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

Trotter, C. L., & Ramsay, M. E. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00053.x · Cited by 159 · see citing works

The Meningitis Vaccine Project

LaForce, F. M., Konde, K., Viviani, S., & Préziosi, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.049 · Cited by 158 · see citing works

Haemophilus influenzae type b conjugate vaccine use and effectiveness

Morris, S. K., Moss, W. J., & Halsey, N. A. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70152-x · Cited by 157 · see citing works

A surveillance network for meningococcal disease in Europe

Trotter, C. L., Chandra, M., Cano, R., Larrauri, A., Ramsay, M. E., Brehony, C., Jolley, K. A., Maiden, M. C. J., Heuberger, S., & Frosch, M. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00060.x · Cited by 149 · see citing works

Meningococcal conjugate vaccines: new opportunities and new challenges

Maiden, M. C. J., & Spratt, B. G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00252-4 · Cited by 146 · see citing works

Conjugate vaccines

Goldblatt, D. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01109.x · Cited by 142 · see citing works

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

Trotter, C. L., McVernon, J., Ramsay, M. E., Whitney, C. G., Mulholland, K., Goldblatt, D., Hombach, J., & Kiény, M.-P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.073 · Cited by 140 · see citing works

PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS

de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & ENDE, A. V. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000195594.41449.c6 · Cited by 130 · see citing works

The natural history of meningococcal carriage and disease

Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805005339 · Cited by 120 · see citing works

Mortality in severe meningococcal disease

Thorburn, K. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.5.382 · Cited by 113 · see citing works

Genetic Basis for NongroupableNeisseria meningitidis

Dolan‐Livengood, J. M., Miller, Y. K., Martin, L. E., Urwin, R., & Stephens, D. S. (2003) · The Journal of Infectious Diseases · doi:10.1086/374740 · Cited by 103 · see citing works

Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight- Year Longitudinal Study in Northern Ghana

Leimkugel, J., Hodgson, A., Forgor, A. A., Pflüger, V., Dangy, J., Smith, T., Achtman, M., Gagneux, S., & Pluschke, G. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040101 · Cited by 102 · see citing works

Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine

Wals, P. D. (2004) · JAMA · doi:10.1001/jama.292.20.2491 · Cited by 101 · see citing works

Lack of Serum Bactericidal Activity in Preschool Children Two Years After a Single Dose of Serogroup C Meningococcal Polysaccharide-Protein Conjugate Vaccine

Snape, M. D., Kelly, D. F., Green, B., Moxon, E. R., Borrow, R., & Pollard, A. J. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000151029.58752.27 · Cited by 98 · see citing works

Vaccination Coverage Among Adolescents Aged 13-17 Years—United States, 2007

(2009) · JAMA · doi:10.1001/jama.2009.133 · Cited by 94 · see citing works

Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.

Trotter, C. L., Ramsay, M. E., & Kaczmarski, E. B. (2002) · PubMed · Cited by 90 · see citing works

Rapid Serogroup Switching inNeisseria meningitidis

Vogel, U. F., Claus, H., & Frosch, M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420319 · Cited by 78 · see citing works

The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba

Rodríguez, A. E. P., Dickinson, F., Baly, A., & Martínez, R. (1999) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02761999000400002 · Cited by 76 · see citing works

Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study

McVernon, J., Trotter, C. L., Slack, M., & Ramsay, M. E. (2004) · BMJ · doi:10.1136/bmj.329.7467.655 · Cited by 71 · see citing works

Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era

Trotter, C. L., Borrow, R., Findlow, J., Holland, A., Frankland, S., Andrews, N. J., & Miller, E. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00279-08 · Cited by 70 · see citing works

Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine

(2007) · PsycEXTRA Dataset · doi:10.1037/e669332007-003 · Cited by 66 · see citing works

“Love's labours lost”: failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

Robbins, J. B., Towne, D. W., Gotschlich, E. C., & Schneerson, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03227-3 · Cited by 65 · see citing works

Handbook of Meningococcal Disease

(2006) · Wiley eBooks · doi:10.1002/3527608508 · Cited by 62 · see citing works

Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger

Chanteau, S., Sidikou, F., Djibo, S., Moussa, A., Mindadou, H., & Boisier, P. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.09.006 · Cited by 61 · see citing works

Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci

Dellicour, S., & Greenwood, B. M. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01929.x · Cited by 59 · see citing works

The epidemiology of meningococcal disease in Norway 1975-91.

LYSTAD, A., & Aasen, S. (1991) · PubMed · Cited by 54 · see citing works

From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease

O’Hallahan, J., LENNON, D. R., Oster, P., Lane, R. W., Reid, S., Mulholland, K., STEWART, J. M., Penney, L., Percival, T., & MARTIN, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.061 · Cited by 51 · see citing works

Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis

Pérez‐Trallero, E., Vicente, D. A., Montes, M., & Cisterna, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11061-0 · Cited by 46 · see citing works

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales

Trotter, C. L., Ramsay, M. E., Gray, S., Fox, A., & Kaczmarski, E. B. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70584-9 · Cited by 46 · see citing works

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making

Welte, R., van den Dobbelsteen, G. P. J. M., BOS, J., de Melker, H., van Alphen, L., Spanjaard, L., Rümke, H. C., & Postma, M. J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.019 · Cited by 45 · see citing works

Strategies for Development of Universal Vaccines Against Meningococcal Serogroup B Disease

Holst, J. (2007) · Human Vaccines · doi:10.4161/hv.4513 · Cited by 45 · see citing works

Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000–2006

Kinlin, L. M., Jamieson, F., Brown, E. M., Brown, S., Rawte, P., Dolman, S., Drews, S. J., & Fisman, D. N. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.026 · Cited by 44 · see citing works

Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers

Weber, M. V. R., Claus, H., Maiden, M. C. J., Frosch, M., & Vogel, U. F. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.05.004 · Cited by 37 · see citing works

NON-USEFULNESS OF MENINGOCOCCAL CARRIAGE-RATES

Wenzel, R., Davies, J., Mitzel, J. R., & Beam, W. E. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93037-7 · Cited by 36 · see citing works

Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluation

DeWals, P., Trottier, P., & Pépin, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.010 · Cited by 36 · see citing works

Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria

Zhang, Q., & Finn, A. H. R. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.016253 · Cited by 35 · see citing works

Vaccines for the Unvaccinated: Protecting the Herd

Stephens, D. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/527402 · Cited by 33 · see citing works

Meningococcal C vaccines: the Canadian experience.

Wals, P. D. (2004) · PubMed · Cited by 25 · see citing works

"Herd immunity" and the meningococcal vaccine trial in Norway

BJUNE, G. (1992) · The Lancet · doi:10.1016/0140-6736(92)92411-8 · Cited by 21 · see citing works

The changing face of meningococcal disease in West Africa

Greenwood, B. M. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807008825 · Cited by 21 · see citing works

B:2a:P1.5 Meningococcal Strains Likely Arisen from Capsular Switching Event Still Spreading in Spain

Castilla, J., Vázquez, J. A., Salcedo, C., Cenoz, M. G., García-Irure, J. J., Torroba, L., Beristain, X., Abad, R., & Barricarte, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01495-08 · Cited by 21 · see citing works

The EUVAC-NET project: creation and operation of a surveillance community network for vaccine preventable infectious diseases

Glismann, S., Rønne, T., & Tozzi, A. E. (2001) · Eurosurveillance · doi:10.2807/esm.06.06.00204-en · Cited by 20 · see citing works

Meningococcal C Vaccines

Wals, P. D. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000147643.95195.37 · Cited by 17 · see citing works

Surrogates of Protection

Halloran, M. E., Longini, I. M., & Struchiner, C. J. (2009) · Statistics for biology and health · doi:10.1007/978-0-387-68636-3_15 · Cited by 16 · see citing works

Surrogates of Protection

Borrow, R., & Miller, E. J. (2006) · doi:10.1002/3527608508.ch16 · Cited by 16 · see citing works

Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003

Law, D. K. S., Stoltz, J., Henderson, A. M., & Tsang, R. S. W. (2005) · Canadian Journal of Microbiology · doi:10.1139/w05-085 · Cited by 14 · see citing works

Meningococcal C booster not recommended by evidence

Thomas, H. L., Andrews, N., Trotter, C. L., Ramsay, M. E., & Miller, E. (2008) · BMJ · doi:10.1136/bmj.a1139 · Cited by 9 · see citing works

Conjugate Vaccines

Ravenscoft, N., & Feavers, I. M. (2006) · doi:10.1002/3527608508.ch17 · Cited by 3 · see citing works

Neisseria meningitidis carriage by age: a systematic review

Christensen, H., Trotter, C. L., Bowen, L., & Hickman, M. (2008) · Bristol Research (University of Bristol) · Cited by 2 · see citing works

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593 · see citing works

Meningococcal carriage by age: a systematic review and meta-analysis

Christensen, H., May, M., Bowen, L., Hickman, M., & Trotter, C. L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70251-6 · Cited by 650 · see citing works

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

Read, R. C., Baxter, D. N., Chadwick, D., Faust, S. N., Finn, A. H. R., Gordon, S. B., Heath, P. T., Lewis, D. J., Pollard, A. J., Turner, D. P. J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60842-4 · Cited by 282 · see citing works

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Borrow, R., Alarcón, P., Carlos, J., Caugant, D. A., Christensen, H., Debbag, R., Wals, P. D., Echániz-Avilés, G., Findlow, J., Head, C., et al. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1258308 · Cited by 273 · see citing works

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

Bino, L. D., Østerlid, K. E., Wu, D., Nonne, F., Romano, M. R., Codée, J. D. C., & Adamo, R. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00021 · Cited by 207 · see citing works

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A. J., Sullivan, T., MacLennan, J. M., Maiden, M. C. J., Ladhani, S. N., Ramsay, M. E., Trotter, C. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900236 · Cited by 188 · see citing works

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

Novak, R. T., Kambou, J. L., Diomandé, F. V. K., Tarbangdo, F., Ouedraogo-Traoré, R., Sangaré, L., Lingani, C., Martin, S. W., Hatcher, C., Mayer, L. W., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70168-8 · Cited by 155 · see citing works

Bexsero

GORRINGE, A. R., & Pajón, R. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18500 · Cited by 131 · see citing works

Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact

Christensen, H., Hickman, M., Edmunds, W. J., & Trotter, C. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.034 · Cited by 130 · see citing works

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications

Bröker, M., Costantino, P., DeTora, L. M., McIntosh, E. D. G., & Rappuoli, R. (2011) · Biologicals · doi:10.1016/j.biologicals.2011.05.004 · Cited by 129 · see citing works

Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study

Deasy, A. M., Guccione, E., Dale, A. P., Andrews, N., Evans, C. M., Bennett, J. S., Bratcher, H. B., Maiden, M. C. J., Gorringe, A. R., & Read, R. C. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ098 · Cited by 125 · see citing works

Modelling the Epidemiology of Infectious Diseases for Decision Analysis

Jit, M., & Brisson, M. (2011) · PharmacoEconomics · doi:10.2165/11539960-000000000-00000 · Cited by 117 · see citing works

Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease

McNeil, L. K., Zagursky, R. J., Lin, S. L., Murphy, E., Zlotnick, G. W., Hoiseth, S. K., Jansen, K. U., & Anderson, A. S. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00056-12 · Cited by 115 · see citing works

Vaccination and herd immunity

Rashid, H., Khandaker, G., & Booy, R. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328352f727 · Cited by 111 · see citing works

Early Impact of the US Tdap Vaccination Program on Pertussis Trends

Cohn, A. C. (2012) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2011.1093 · Cited by 93 · see citing works

Effectiveness of meningococcal serogroup C vaccine programmes

Borrow, R., Abad, R., Trotter, C., van der Klis, F. R. M., & Vazquez, J. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.083 · Cited by 88 · see citing works

A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination

Bijlsma, M. W., Brouwer, M. C., Spanjaard, L., van de Beek, D., & ENDE, A. V. D. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu601 · Cited by 87 · see citing works

The next decade of vaccines: societal and scientific challenges

Moxon, E. R., & Siegrist, C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60407-8 · Cited by 87 · see citing works

Chronic hepatitis B infection in adolescents who received primary infantile vaccination

Wu, T., Lin, H. H., & Wang, L. (2012) · Hepatology · doi:10.1002/hep.25988 · Cited by 84 · see citing works

The spectrum of acute bacterial meningitis in elderly patients

Domingo, P., Pomar, V., de Benito, N., & Coll, P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-108 · Cited by 74 · see citing works

Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015–2016

McNamara, L. A., Thomas, J. D., MacNeil, J., Chang, H. Y., Day, M., Fisher, E., Martin, S., Poissant, T., Schmink, S. E., Steward-Clark, E., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix446 · Cited by 72 · see citing works

Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature

Balmer, P., Burman, C., Serra, L., & York, L. J. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1454570 · Cited by 68 · see citing works

Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y

Cooper, B. W., DeTora, L. M., & Stoddard, J. J. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.147 · Cited by 64 · see citing works

Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants inNeisseria meningitidisprotein vaccines

Sanders, H., & Feavers, I. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.10 · Cited by 64 · see citing works

In Vivo Adaptation and Persistence of Neisseria meningitidis within the Nasopharyngeal Mucosa

Johswich, K. O., McCaw, S. E., Islam, E. A., Sintsova, A., Gu, A., Shively, J. E., & Gray‐Owen, S. D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003509 · Cited by 63 · see citing works

Meningococcal glycoconjugate vaccines

Gasparini, R., & Panatto, D. (2011) · Human Vaccines · doi:10.4161/hv.7.2.13717 · Cited by 61 · see citing works

The epidemiology of meningococcal disease in Latin America 1945–2010: an unpredictable and changing landscape

Sáfadi, M. A. P., Ayala, S. E. G., Jäkel, A., Wieffer, H., Moreno, C. S., & Vyse, A. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812001689 · Cited by 61 · see citing works

Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine

MacNeil, J. R., Cohn, A. C., Zell, E. R., Schmink, S. E., Miller, E. R., Clark, T. A., & Messonnier, N. E. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820a8b3c · Cited by 58 · see citing works

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex

Stoof, S. P., Rodenburg, G. D., Knol, M. J., Rümke, L. W., Man-Bovenkerk, S., Berbers, G. A. M., Spanjaard, L., ENDE, A. V. D., & Sanders, E. A. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ506 · Cited by 56 · see citing works

Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention

Ceyhan, M., Anis, S., Htun-Myint, L., Pawinski, R., Soriano‐Gabarró, M., & Vyse, A. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.03.011 · Cited by 55 · see citing works

Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage

Gabutti, G., Stefanati, A., & Kuhdari, P. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2015.56.3.478 · Cited by 53 · see citing works

Carriage ofNeisseria meningitidisin Europe: a review of studies undertaken in the region

Soriano‐Gabarró, M., Wolter, J. M., Hogea, C. S., & Vyse, A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.89 · Cited by 53 · see citing works

Dissecting the indirect effects caused by vaccines into the basic elements

Lefebvre, C. D. S., Terlinden, A., & Standaert, B. A. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1052196 · Cited by 52 · see citing works

Cost-effectiveness of vaccination against meningococcal B among Dutch infants

Pouwels, K. B., Hak, E., ENDE, A. V. D., Christensen, H., van den Dobbelsteen, G. P. J. M., & Postma, M. J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23888 · Cited by 52 · see citing works

Effectiveness of Serogroup C Meningococcal Conjugate Vaccine

Wals, P. D., Deceuninck, G., Lefebvre, B., Boulianne, N., & Serres, G. D. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820e8638 · Cited by 52 · see citing works

Meningococcal carriage in high-risk settings: A systematic review

Peterson, M. E., Mile, R., Li, Y., Nair, H., & Kyaw, M. H. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.05.022 · Cited by 52 · see citing works

Factors contributing to the immunogenicity of meningococcal conjugate vaccines

Bröker, M., Berti, F., & Costantino, P. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1153206 · Cited by 51 · see citing works

Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

Borja-Tabora, C., Montalban, C., Memish, Z. A., der Wielen, M. V., Bianco, V., Boutriau, D., & Miller, J. M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-116 · Cited by 50 · see citing works

The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?

Maiden, M. C. J. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0147 · Cited by 47 · see citing works

Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative

Borrow, R., Lee, J. S., Vázquez, J. A., Enwere, G., Taha, M., Kamiya, H., Kim, H. M., & Jo, D. S. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.022 · Cited by 47 · see citing works

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

Haidara, F. C., Umesi, A., Sow, S. O., Ochoge, M., Diallo, F., Imam, A., Traore, Y., Affleck, L., Doumbia, M. F., Daffeh, B., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2214924 · Cited by 45 · see citing works

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010

Sáfadi, M. A. P., Carvalhanas, T. R. M. P., de Lemos, A. P. S., Gorla, M. C., Salgado, M. M., Fukasawa, L. O., Gonçalves, M. G., Higa, F. T., Brandileone, M. C. D. C., Sacchi, C. T., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2005.130948 · Cited by 45 · see citing works

Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation

Ibarz-Pavón, A. B., MacLennan, J. M., Andrews, N., Gray, S. J., Urwin, R., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir466 · Cited by 45 · see citing works

A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine

Read, R. C., Dull, P. M., Bai, X., Nolan, K., Findlow, J., Bazaz, R., Kleinschmidt, A., McCarthy, M. C., Wang, H., Toneatto, D., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.071 · Cited by 44 · see citing works

Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis

Peterson, M. E., Li, Y., Shanks, H., Mile, R., Nair, H., & Kyaw, M. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024343 · Cited by 44 · see citing works

Vaccination strategies for the prevention of meningococcal disease

Vuocolo, S. C., Balmer, P., Gruber, W. C., Jansen, K. U., Anderson, A. S., Perez, J. L., & York, L. J. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1451287 · Cited by 42 · see citing works

Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme

Tirani, M., Meregaglia, M., & Melegaro, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123383 · Cited by 40 · see citing works

Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years

Gasparini, R., Comanducci, M., Amicizia, D., Ansaldi, F., Canepa, P., Orsi, A., Icardi, G., Rizzitelli, E., Angelis, G. D., Bambini, S., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03584-13 · Cited by 40 · see citing works

Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands

Hepkema, H., Pouwels, K. B., ENDE, A. V. D., Westra, T. A., & Postma, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065036 · Cited by 40 · see citing works

Product review on the IMD serogroup B vaccine Bexsero®

Deghmane, A., & Taha, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2020043 · Cited by 39 · see citing works

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results

MacLennan, J. M., Rodrigues, C. M. C., Bratcher, H. B., Lekshmi, A., Finn, A. H. R., Oliver, J., Wootton, M., Ray, S., Cameron, C., Smith, A. J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30842-2 · Cited by 39 · see citing works

Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)

Croxtall, J. D., & Dhillon, S. (2012) · Drugs · doi:10.2165/11209580-000000000-00000 · Cited by 38 · see citing works

Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents

McMillan, M., Wang, B., Koehler, A. P., Sullivan, T., & Marshall, H. S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1636 · Cited by 38 · see citing works

Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial

Dbaibo, G. S., El-Ayoubi, N. K., Ghanem, S., Hajar, F., Bianco, V., Miller, J. M., & Mesaros, N. E. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0065-0 · Cited by 37 · see citing works

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study

Ohm, M., Hahné, S., ENDE, A. V. D., Sanders, E. A. M., Berbers, G. A. M., Ruijs, W. L. M., van Sorge, N. M., de Melker, H. E., & Knol, M. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab791 · Cited by 37 · see citing works

Prevalence, Risk Factors and Molecular Characteristics of Meningococcal Carriage Among Brazilian Adolescents

de Moraes, J. C., Kemp, B., de Lemos, A. P. S., Gorla, M. C., Marques, E. G. L., Ferreira, M. D. C., Sacchi, C. T., Carvalhanas, T. R. M. P., Ribeiro, A. F., Ferreira, C. M., et al. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000853 · Cited by 37 · see citing works

Recent Progress in the Prevention of Serogroup B Meningococcal Disease

Feavers, I. M., & Maiden, M. C. J. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00566-16 · Cited by 36 · see citing works

Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile

Villena, R., Valenzuela, M. T., Bastías, M., & Santolaya, M. E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.050 · Cited by 36 · see citing works

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines

Vesikari, T., Forstén, A., Bianco, V., der Wielen, M. V., & Miller, J. M. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000897 · Cited by 34 · see citing works

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis

Gasparini, R., Landa, P., Amicizia, D., Icardi, G., Ricciardi, W., de Waure, C., Tànfani, E., Bonanni, P., Lucioni, C., Testi, A., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1160177 · Cited by 34 · see citing works

Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis

Cooper, L., Kristiansen, P. A., Christensen, H., Karachaliou, A., & Trotter, C. L. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819001134 · Cited by 33 · see citing works

Meningococcal disease in North America: Updates from the Global Meningococcal Initiative

Asturias, E. J., Bai, X., Bettinger, J. A., Borrow, R., Castillo, D. N., Caugant, D. A., Chacón, G. C., Dinleyici, E. Ç., Echániz-Avilés, G., García, L. G., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.10.022 · Cited by 33 · see citing works

The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

Anonychuk, A. M., Woo, G. W., Vyse, A., Demarteau, N., & Tricco, A. C. (2013) · PharmacoEconomics · doi:10.1007/s40273-013-0057-2 · Cited by 33 · see citing works

Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial

Borja-Tabora, C., Montalban, C., Memish, Z. A., Boutriau, D., Kolhe, D. A., Miller, J. M., & der Wielen, M. V. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1138-y · Cited by 32 · see citing works

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies

Sáfadi, M. A. P., & McIntosh, E. D. G. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.159 · Cited by 32 · see citing works

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections

Jones, C. H., Mohamed, N., Rojas, E. A. P., Andrew, L., Hoyos, J. M., Hawkins, J. C., McNeil, L. K., Jiang, Q. L., Mayer, L. W., Wang, X., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01447-15 · Cited by 31 · see citing works

Expert Review of Vaccines

Bettinger, J. A., Deeks, S. L., Halperin, S. A., Tsang, R. S. W., & Scheifele, D. W. (2013) · Cited by 31 · see citing works

The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative

Sáfadi, M. A. P., Monteros, L. E. E. D. L., López, E. L., Sáez‐Llorens, X., Lemos, A. P., Moreno‐Espinosa, S., Ayala, S. G., Torres, J. P., de Moraes, J. C., & Vázquez, J. A. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.814879 · Cited by 30 · see citing works

The Burden of Pediatric Invasive Meningococcal Disease in Spain (2008–2013)

Calle, I. R., Vilanova‐Trillo, L., Pardo‐Seco, J., Salvado, L. B., Illade, L., & Martinón‐Torres, F. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001048 · Cited by 30 · see citing works

Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame

Loh, E., Lavender, H., Tan, F., Tracy, A., & Tang, C. M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005794 · Cited by 30 · see citing works

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents

Sáez‐Llorens, X., Vaca, D. C. A., Abarca, K., V, Maho, E., Graña, M. G., Heijnen, E., Smolenov, I. V., & Dull, P. M. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1029686 · Cited by 29 · see citing works

B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents

Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A. J., MacLennan, J. M., Maiden, M. C. J., Ramsay, M. E., Ladhani, S. N., Trotter, C. L., Borrow, R., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020988 · Cited by 28 · see citing works

New frontiers in meningococcal vaccines

Anderson, A. S., Jansen, K. U., & Eiden, J. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.50 · Cited by 27 · see citing works

Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with HIV in Rio de Janeiro, Brazil

Frota, A. C. C., Milagres, L. G., Harrison, L. H., Ferreira, B., Barreto, D. M., Pereira, G. S., Cruz, A. C., PEREIRA-MANFRO, W. F., de Oliveira, R. H., de Abreu, T. F., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000630 · Cited by 27 · see citing works

A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines

Sáfadi, M. A. P., Berezin, E. N., & Oselka, G. W. (2012) · Jornal de Pediatria · doi:10.2223/jped.2167 · Cited by 27 · see citing works

Hajj vaccinations—facts, challenges, and hope

Ghany, M. A. E., Sharaf, H., & Hill-Cawthorne, G. A. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.05.024 · Cited by 27 · see citing works

Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students

Oldfield, N. J., Green, L. R., Parkhill, J., Bayliss, C. D., & Turner, D. P. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix596 · Cited by 27 · see citing works

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil

Nunes, A. M. P. B., Ribeiro, G. S., Ferreira, Í. E., Moura, A. R. S. S., Felzemburgh, R. D. M., de Lemos, A. P. S., dos Reis, M. G., de Moraes, J. C., & Campos, L. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166475 · Cited by 26 · see citing works

Carbohydrate based meningococcal vaccines: past and present overview

Berti, F., Romano, M. R., Micoli, F., & Adamo, R. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-09990-y · Cited by 26 · see citing works

The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy

Rollier, C. S., Dold, C., Marsay, L., Sadarangani, M., & Pollard, A. J. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.983897 · Cited by 25 · see citing works

MenACWY-TT vaccine for active immunization against invasive meningococcal disease

Papaevangelou, V., & Spyridis, Ν. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.32 · Cited by 25 · see citing works

Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria

Ferrari, M. J., Fermon, F., Nackers, F., Llosa, A. E., Magone, C., & Grais, R. F. (2014) · International Health · doi:10.1093/inthealth/ihu062 · Cited by 25 · see citing works

Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2014

Moreno‐Pérez, D., García, F. J. Á., Fernández, J. A., Ortega, M. J. C., Rauet, J. M. C., Sánchez, N. G., Merino, Á. H., Matos, T. H.-S., Moína, M. M., del Castillo, L. O., et al. (2014) · Anales de Pediatría · doi:10.1016/j.anpedi.2013.10.006 · Cited by 25 · see citing works

Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT

Findlow, H., & Borrow, R. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0032-5 · Cited by 24 · see citing works

Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers

Stoof, S. P., van der Klis, F. R. M., van Rooijen, D. M., Knol, M. J., Sanders, E. A. M., & Berbers, G. A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100651 · Cited by 23 · see citing works

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs

Htar, M. T. T., Jackson, S., Balmer, P., Serra, L., Vyse, A., Slack, M., Riera-Montes, M., Swerdlow, D. L., & Findlow, J. (2020) · BMC Public Health · doi:10.1186/s12889-020-09946-1 · Cited by 23 · see citing works

Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines

Rojas, E. A. P., Hoyos, J. M., Oldfield, N. J., Lee, P., Flint, M., Jones, C. H., Ala’Aldeen, D. A. A., Jansen, K. U., & Anderson, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132140 · Cited by 21 · see citing works

Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US

Davis, K. L., BELL, T. J., Miller, J. M., Misurski, D. A., & Bapat, B. (2011) · Applied Health Economics and Health Policy · doi:10.2165/11587330-000000000-00000 · Cited by 21 · see citing works

Neisseria meningitidis

Stephens, D. S., & Apicella, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00213-7 · Cited by 20 · see citing works

Evaluation of serogroup C and ACWY meningococcal vaccine programs: Projected impact on disease burden according to a stochastic two-strain dynamic model

Vickers, D., Anonychuk, A. M., Wals, P. D., Demarteau, N., & Bauch, C. T. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.034 · Cited by 20 · see citing works

Real-world impact and effectiveness of MenACWY-TT

Villena, R., Kriz, P., Htar, M. T. T., Burman, C., Findlow, J., Balmer, P., & Jódar, L. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2251825 · Cited by 19 · see citing works

Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada

Wals, P. D., & Zhou, Z. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001512 · Cited by 19 · see citing works

Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review

Santos-Neto, J. F., Ferreira, V. M., Feitosa, C. A., Martinez-Silveira, M. S., & Campos, L. C. (2019) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2019.06.006 · Cited by 19 · see citing works

Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction

Villena, R., Valenzuela, M. T., Bastías, M., & Santolaya, M. E. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.11.075 · Cited by 19 · see citing works

The epidemiology and outcomes of central nervous system infections in Far North Queensland, tropical Australia; 2000-2019

Gora, H., Smith, S., Wilson, I., Preston‐Thomas, A., Ramsamy, N., & Hanson, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265410 · Cited by 19 · see citing works

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool

Stoof, S. P., van der Klis, F. R. M., van Rooijen, D. M., Bogaert, D., Trzciński, K., Sanders, E. A. M., & Berbers, G. A. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.055 · Cited by 19 · see citing works

Can we, should we, eradicate the meningococcus?

Maiden, M. C. J., & Frosch, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.068 · Cited by 18 · see citing works

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

García, Y. R., Abitbol, V., Pellegrini, M., Bekkat-Berkani, R., & Soumahoro, L. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00519-2 · Cited by 18 · see citing works

A mixed-methods study to identify factors associated with MenACWY vaccine uptake, barriers and motivations towards vaccination among undergraduate students

Trayner, K. M. A., Anderson, N., & Cameron, J. C. (2018) · Health Education Journal · doi:10.1177/0017896918796049 · Cited by 17 · see citing works

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination

Tan, L., Sáfadi, M. A. P., Horn, M. R., Balboa, C. R., Moya, E., Schanbaum, J., Pimenta, P., Lambert, E., Soumahoro, L., Sohn, W.-Y., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2179840 · Cited by 16 · see citing works

Transmission dynamic models of meningococcal carriage, disease and the impact of serogroup C conjugate vaccination

Trotter, C. (2005) · Bristol Research (University of Bristol)

Vaccines for the Unvaccinated: Protecting the Herd

Stephens, D. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/527402 · Cited by 33 · see citing works

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442 · see citing works

Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination

Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi160 · Cited by 176 · see citing works

A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination

Bijlsma, M. W., Brouwer, M. C., Spanjaard, L., van de Beek, D., & ENDE, A. V. D. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu601 · Cited by 87 · see citing works